164 related articles for article (PubMed ID: 25820065)
1. Socioeconomic status and HIV vaccine preparedness studies in North America.
Dhalla S; Poole G
Vaccine; 2015 May; 33(22):2536-45. PubMed ID: 25820065
[TBL] [Abstract][Full Text] [Related]
2. Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-negative injection drug users.
Dhalla S; Poole G; Singer J; Patrick DM; Wood E; Kerr T
Vaccine; 2010 Feb; 28(7):1663-7. PubMed ID: 20044049
[TBL] [Abstract][Full Text] [Related]
3. Effect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical prevention.
Dhalla S; Poole G
Hum Vaccin Immunother; 2014; 10(7):1974-84. PubMed ID: 25424807
[TBL] [Abstract][Full Text] [Related]
4. HIV vaccine preparedness studies in the organization for economic co-operation and development (OECD) countries.
Dhalla S; Woods R; Strathdee SA; Patrick DM; Hogg RS
AIDS Care; 2007 Oct; 19(9):1118-27. PubMed ID: 17851989
[TBL] [Abstract][Full Text] [Related]
5. Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India: a social ecological approach.
Chakrapani V; Newman PA; Singhal N; Jerajani J; Shunmugam M
PLoS One; 2012; 7(12):e51080. PubMed ID: 23226560
[TBL] [Abstract][Full Text] [Related]
6. Contextualizing willingness to participate: recommendations for engagement, recruitment & enrolment of Kenyan MSM in future HIV prevention trials.
Doshi M; Avery L; Kaddu RP; Gichuhi M; Gakii G; du Plessis E; Dutta S; Khan S; Kimani J; Lorway RR
BMC Public Health; 2017 May; 17(1):469. PubMed ID: 28521748
[TBL] [Abstract][Full Text] [Related]
7. Predicting hypothetical willingness to participate (WTP) in a future phase III HIV vaccine trial among high-risk adolescents.
Giocos G; Kagee A; Swartz L
AIDS Behav; 2008 Nov; 12(6):842-51. PubMed ID: 17668313
[TBL] [Abstract][Full Text] [Related]
8. Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial.
O'Connell JM; Hogg RS; Chan K; Strathdee SA; McLean N; Martindale SL; Willoughby B; Remis R
J Acquir Immune Defic Syndr; 2002 Dec; 31(5):521-8. PubMed ID: 12473841
[TBL] [Abstract][Full Text] [Related]
9. Willingness to participate in HIV vaccine clinical trials among Chinese men who have sex with men.
Li Q; Luo F; Zhou Z; Li S; Liu Y; Li D; Shi W; Raymond HF; Ruan Y; Shao Y
Vaccine; 2010 Jun; 28(29):4638-43. PubMed ID: 20452428
[TBL] [Abstract][Full Text] [Related]
10. Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-positive injection drug users.
Dhalla S; Poole G; Singer J; Patrick DM; Kerr T
Psychol Health Med; 2012; 17(2):223-34. PubMed ID: 22250925
[TBL] [Abstract][Full Text] [Related]
11. Pilot study assessing HIV vaccine trial readiness among female sex workers, injection and non-injection drug users, and men who have sex with men in Spain.
Etcheverry MF; de Lazzari E; Fuchs JD; Meroño M; Sierra E; Del Romero J; Evans JL; Mendez-Arancibia E; Jacques C; Rojas D; Segú M; Gatell JM; Joseph J
AIDS Behav; 2010 Jun; 14(3):607-17. PubMed ID: 19037720
[TBL] [Abstract][Full Text] [Related]
12. Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India.
Newman PA; Chakrapani V; Weaver J; Shunmugam M; Rubincam C
Vaccine; 2014 Oct; 32(44):5854-61. PubMed ID: 25173475
[TBL] [Abstract][Full Text] [Related]
13. Willingness of female sex workers in Kampala, Uganda to participate in future HIV vaccine trials: a case control study.
Mayanja Y; Abaasa A; Namale G; Price MA; Kamali A
BMC Public Health; 2020 Nov; 20(1):1789. PubMed ID: 33239018
[TBL] [Abstract][Full Text] [Related]
14. Willingness to participate in HIV vaccine trials among a sample of men who have sex with men, with and without a history of commercial sex, Rio de Janeiro, Brazil.
de Souza CT; Lowndes CM; Szwarcwald CL; Sutmöller F; Bastos FI
AIDS Care; 2003 Aug; 15(4):539-48. PubMed ID: 14509868
[TBL] [Abstract][Full Text] [Related]
15. Willingness to participate in HIV vaccine trials: the impact of trial attributes.
Newman PA; Duan N; Lee SJ; Rudy E; Seiden D; Kakinami L; Cunningham W
Prev Med; 2007 Jun; 44(6):554-7. PubMed ID: 17275895
[TBL] [Abstract][Full Text] [Related]
16. Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users.
Golub ET; Purvis LA; Sapun M; Safaeian M; Beyrer C; Vlahov D; Strathdee SA
AIDS Behav; 2005 Sep; 9(3):301-9. PubMed ID: 16088366
[TBL] [Abstract][Full Text] [Related]
17. Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda.
Asiki G; Abaasa A; Ruzagira E; Kibengo F; Bahemuka U; Mulondo J; Seeley J; Bekker LG; Delany S; Kaleebu P; Kamali A
Vaccine; 2013 Oct; 31(44):5055-61. PubMed ID: 24021306
[TBL] [Abstract][Full Text] [Related]
18. Response to Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial.
Halpern SD
J Acquir Immune Defic Syndr; 2003 Jul; 33(3):412. PubMed ID: 12843757
[No Abstract] [Full Text] [Related]
19. Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol Team.
Koblin BA; Holte S; Lenderking B; Heagerty P
J Acquir Immune Defic Syndr; 2000 Aug; 24(5):451-7. PubMed ID: 11035616
[TBL] [Abstract][Full Text] [Related]
20. Young men who have sex with men's awareness, acceptability, and willingness to participate in HIV vaccine trials: Results from a nationwide online pilot study.
Connochie D; Tingler RC; Bauermeister JA
Vaccine; 2019 Oct; 37(43):6494-6499. PubMed ID: 31522806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]